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Abstract
Introduction: The use of frozen section analysis is of considerable importance for the diagnosis of borderline ovarian tumors (BOTs) and to plan the most appropriate 
surgical management. The aim of this study is to determine the accuracy of frozen section in diagnosing BOTs. 
Material and methods: This is a retrospective study. A computerized database was used to identify all pathology reports (frozen section analysis and/or definitive 
histology) with a diagnosis of BOTs performed at our institution between January 2004 and December 2015. Frozen section analysis and definitive histology reports 
were compared.
Results: 98 BOTs were diagnosed by frozen and/or permanent section pathology in 88 women. The sensitivity of frozen section for diagnosing BOTs was 76.5%; 
the positive predictive value was 83.3%. The sensitivity of frozen section for diagnosing serous BOTs was significantly higher than for diagnosing mucinous BOTs. 
Underdiagnosis occurred in 32.7% of the tumors; it was less frequent in serous tumors than in mucinous tumors. BOTs underdiagnosed at frozen section were 
significantly larger than those accurately diagnosed at frozen section. In 13 women, frozen section diagnosed BOTs were upgraded to invasive ovarian carcinoma by 
permanent pathology; there were two relapses in these patients after a mean follow-up of 47.8 months. No recurrence was observed after a mean follow-up of 60.4 
months in 19 women with BOTs underdiagnosed as benign tumors at frozen section.
Discussion: the surgical management of BOTs based only on intraoperative frozen section diagnosis may result in undertreatment or overtreatment of a substantial 
number of patients. Under-diagnosis by frozen section is associated with conservative surgery but it does not compromise the outcome in patients with BOTs.
Correspondence to: Simone Ferrero MD, PhD, Academic Unit of Obstetrics and 
Gynecology, IRCCS AOU San Martino – IST, Largo R. Benzi 10, 16132 Genoa, 
Italy, Tel: +01139 010 511525; Fax: +01139 010511525; E-mail: simone.ferrero@
unige.it
Key words: accuracy, borderline tumors of the ovary, frozen section, diagnosis, 
ovarian tumors
Received: March 17, 2018; Accepted: March 29, 2018; Published: April 05, 2018
Introduction
Borderline ovarian tumors (BOTs) are a distinct diagnostic 
category of epithelial ovarian tumor, distinguished from both benign 
epithelial ovarian tumors and invasive epithelial ovarian cancers [1]. 
BOTs account for 5% of all epithelial ovarian tumors and 15% of all 
epithelial ovarian cancers [2]. BOTs are characterized pathologically 
by features of malignant tumors, including cellular proliferation, 
stratification of the epithelial lining of the papillae, nuclear atypia, and 
mitotic activity, but without destructive stromal invasion [3]. They 
are characterized by earlier stage and younger age at diagnosis, more 
indolent behavior, longer survival, and later recurrence than seen in 
cases of invasive ovarian cancer [4].
The preoperative discrimination between the benign cysts, 
BOTs and invasive cancers is based on patients’ characteristics 
(age, menopausal status), serum markers (mainly CA-125 levels), 
ultrasonographic and radiological imaging (such as magnetic 
resonance imaging and positron emission tomography). However, 
the levels of CA-125 may overlap between patients with benign cysts, 
BOTs and invasive cancers [5]. Similarly, the imaging findings are not 
specific of BOTs [6]. Therefore, the diagnosis of BOTs cannot be surely 
established prior to surgery and intraoperative decisions regarding the 
surgical management should be based on frozen section analysis. 
The accuracy of frozen section analysis is of considerable importance 
in BOTs. Overdiagnosis of BOTs may results in overtreatment while, 
in case of BOTs, a conservative, fertility sparing surgery can be carried 
out in women of reproductive age who wish to retain their fertility. 
Similarly, it is important to discriminate BOTs from benign cysts; 
in fact, patients with a BOT misinterpreted as benign tumor may 
receive an inadequate treatment and staging that result in subsequent 
additional surgical intervention and possible tumor spread.
Frozen section analysis of ovarian tumors has sensitivity between 
65% and 97% and specificity between 97% and 100% in differentiating 
invasive and non-invasive specimens [7]. Frozen section analysis 
of BOTs, however, is notoriously difficult with a significantly lower 
sensitivity and specificity compared to benign tumors of the ovary 
and ovarian cancers [8]. Since BOTs comprise only 10% of epithelial 
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underdiagnosed by frozen section. The χ2 test and the Fisher’s exact 
test were used to compare proportions. Data were archived using Excel 
2007 (Microsoft, Redmond, WA, USA) and analyzed using Sigma Stat 
software version 3.5 (SPSS Science, Chicago, IL, USA). P < 0.05 was 
considered statistically significant.
Results
During the study period, 98 BOTs were diagnosed by frozen and/or 
permanent section pathology in 88 women.
Characteristics of the study population
The mean (± SD) age of the patients was 47.9 ± 18.2 (range 18-
86) years. Forty-eight women were premenopausal. The mean serum 
concentration of CA-125 was 53.6 IU/L (range 3.0 - 369.0 IU/L; n = 
62), of CA-19.9 was 40.8 IU/L (range 6.2 - 324.0 IU/L; n = 62) and of 
CEA was 4.4 ng/ml (range 0.9 - 15.0 ng/ml; n = 55). Fifty-eight tumors 
(59.2%) were histologically serous, 35 tumors (35.7%) were mucinous 
and 5 tumors (5.1%) were mixed. The mean (± SD) tumor diameter 
was 11.9 ± 7.3 (range, 1.5 - 32.0) cm. The mean (± SD) diameter of 
mucinous tumors (17.1 ± 7.1; range, 7.0 - 32.0 cm) was significantly 
greater than the diameter of serous tumors (9.1 ± 5.8 cm; range, 1.5 - 
24.0 cm; p < 0.05) and the diameter of tumors with mixed histology (7.4 
± 3.4 cm; range 4.0 - 12.0 cm; p < 0.05).
After surgery, 56 patients (63.6%) were FIGO IA stage, 10 patients 
(11.3%) IB, 16 patients (18.2 %) IC (3 of them as a consequence of cyst 
rupture), 2 patients (2.7%) IIA, 2 patients (2.7%) IIB, 1 patient (1.3%) 
IIIA, and 1 patient (1.3%) IIIC. 27 patients had fertility-sparing surgery; 
the remaining patients underwent a classic stadiation.
Five women had non-invasive tumor implants (5/88; 5.7%) and 
four women had invasive implants (4/88; 4.5%). Tumor implants 
were localized in the omentum (n = 3), in the pelvic peritoneum (n = 
4), in the pouch of Douglas (n = 1) and in the fallopian tube (n = 1). 
Concurrent endometriosis was diagnosed in 7 cases (8.0%).
Pathological analysis 
Out of 98 tumors included in the study, 78 (79.6%) were diagnosed 
to be BOTs at frozen section. The frozen section diagnosis of BOT 
agreed with permanent pathology diagnosis in 65 of 98 tumors (66.3%; 
95% C.I. 56.1%-75.6%). Using results from paraffin section as a gold 
standard, the sensitivity of frozen section for diagnosing BOTs was 
76.5% (65/85; 95% C.I. 66.0% - 85.0%); the specificity could not be 
calculated because this study included only BOTs diagnosed by frozen 
section and/or permanent pathology. Out of 78 tumors diagnosed as 
BOTs at frozen section, 65 were confirmed to be BOTs at permanent 
pathology (positive predictive value, PPV, 83.3%; 95% C.I., 73.2%-
90.8%). The sensitivity of frozen section for diagnosing serous BOTs 
(86.8%; 46/53; 95% C.I., 74.7%-94.5%) was significantly higher than 
the sensitivity of frozen section for diagnosing mucinous BOTs (59.3%; 
16/27; 95% C.I. 38.8%-77.6%; p = 0.012).
Underdiagnosis occurred in 32.7% of the tumors (32/98). 19 
tumors were interpreted as benign by frozen section and were upgraded 
to BOTs by permanent pathology. 13 frozen sections diagnosed BOTs 
were upgraded to invasive ovarian carcinoma by permanent pathology 
(Table 1). BOTs underdiagnosed by frozen section were significantly 
larger (mean diameter, 14.1 ± 7.7 cm) than those accurately diagnosed 
by frozen section (10.8 ± 6.9; p = 0.035). Underdiagnosis by frozen 
section occurred less frequently in serous tumors (20.7%, 12/58) than 
in mucinous tumors (51.4%, 18/35; p = 0.004). 
ovarian malignancies, studies investigating the accuracy of frozen 
section analysis of BTOs are characterized by a limited number of 
patients. 
This retrospective study aims to provide additional data on the 
accuracy of frozen section in diagnosing BOTs.
Materials and methods
Study design
In this retrospective study, a computerized database was used to 
search all pathology reports (frozen section analysis and/or definitive 
histology) with a diagnosis of BOTs performed at our institution 
between January 2004 and December 2015. The computerized database 
contains all the pathology reports performed at our institution. Only 
cases in which frozen section analysis was performed were considered 
for the analysis. The frozen section diagnosis was compared with the 
final paraffin section diagnosis. Institutional review board approval for 
medical record and pathology report reviews was obtained.
Pathological analysis
The fresh pathologic materials were sent to the pathology department 
immediately after excision. All frozen section specimens were analyzed 
by a pathology resident and a board-certified pathologist, specialized in 
gynecologic pathology. After the measurement of tumor size, the most 
suspected areas of adnexal mass and the solid and papillary areas of the 
tumor wall were chosen for frozen section. Each specimen had at least 
two representative sections sampled for frozen section analysis. Two 
to four of the most representative samples were frozen in a cryostat 
and 5-μm sections were taken and stained with hematoxylin and eosin. 
The number of sections was determined according to the tumor size 
and the number of solid and suspicious areas of the mass. In all cases, 
at least two samples were obtained every 1 cm of maximal tumor 
diameter for paraffin section examination. Histopathologic diagnosis 
was performed according to the criteria of World Health Organization; 
tumors were staged according to the FIGO classification. BOTs were 
defined as follows: epithelial hyperplasia in the form of stratification, 
tufting, cribriform and micropapillary arrangements, atypia (usually 
mild to moderate), detached cell clusters, variable and usually minimal 
mitotic activity, and absence of destructive stromal invasion [1]. 
Mucinous tumors were diagnosed using the criteria defined by 
Hart and Norris [9]. The diagnosis of other tumors was made according 
to the guidelines of Scully [10].
Surgical procedures
Data on patients’ characteristics and surgical procedures 
were retrospectively collected. During the study period, fertility-
sparing surgery was performed in premenopausal women who 
desired childbearing; all the other women were treated with total 
abdominal hysterectomy and bilateral salpingo-oophorectomy, 
abdominal washing, infracolic omentectomy, peritoneal biopsies and 
appendectomy in case of mucinous histotype. Systematic lymph node 
dissection was not performed otherwise in case of intraoperative frozen 
section diagnosis of invasive tumor.
Statistical analysis
The Kruskal-Wallis one-way analysis of variance (with Dunn’s 
multiple comparison post hoc test) was used to compare the diameter 
of tumors with different histology. The Mann-Whitney test was 
used to compare the diameter of tumors correctly diagnosed or 
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Overdiagnosis occurred in 1 tumor (1.0%). One permanent 
pathology proven BOT was diagnosed as malignant at frozen section. 
In no case a tumor diagnosed to be BOT at frozen section was found to 
be benign at permanent pathology (Table 1).
The characteristics of tumors with correct diagnosis at frozen 
section were compared with those of tumors misdiagnosed at frozen 
section (Table 2). This analysis confirmed that serous tumors were 
more frequently correctly diagnosed at frozen section than other 
histotypes (p = 0.004). There was a trend for tumors with larger 
diameter ≤ 5 cm to be more frequently correctly diagnosed than those 
with larger diameter > 5 cm, but the difference did not reach statistical 
significance (p = 0.086). Age of the patients, presence of unilateral of 
bilateral tumors, spread of the tumors outside the ovary, elevation of 
tumor markers, study period and presence of endometriosis did not 
differ between tumors with correct diagnosis at frozen section with 
those misdiagnosed at frozen section (Table 2).
Management of tumors included in the study
19 patients had frozen section diagnosis of benign tumor and 
definitive diagnosis of BTO; none of these tumors was staged during 
the initial surgery. The mean age of these patients was 43.9 years (range 
24-83 years). The histological type of these BOTs was mucinous in 
10 patients, serous in 7 patients and mixed in 2 patients. Of these 19 
women, 4 underwent second surgery for staging purposes, 15 opted 
for a conservative approach with a clinical and radiological follow-up. 
13 frozen sections diagnosed BOTs were upgraded to invasive 
ovarian carcinoma by permanent pathology; the clinical outcomes of 
these patients are shown in (Table 3). Among these 13 patients, seven 
were premenopausal but only three patients wanted to preserve their 
fertility. In one of these premenopausal patients the staging for ovarian 
cancer was actuated for the positive frozen section for mucinous 
ovarian cancer in the omentum. Only two patients underwent fertility-
Permanent pathology
Frozen section Benign Borderline Malignant Total
Benign 0 19 0 19
Borderline 0 65 13 78
Malignant 0 1 0 1
Total 0 85 13 98
Table 1. Frozen diagnosis compared with permanent pathology diagnosis.
Frozen diagnosis compared with permanent diagnosis Details of misdiagnosis
Correct Misdiagnosis p value UnderdiagnosisBTO-Malignant
Underdiagnosis
Benign-BTO Overdiagnosis
Age 0.517
< 35 (n = 30) 18 (60.0%) 12 (40.0%) 4 (13.3%) 8 (26.7%) 0 (0.0%)
> 35 (n = 68) 47 (69.1%) 21 (30.9%) 9 (13.2%) 11 (16.2%) 1 (1.5%)
Tumor size
0.086
> 5 cm (n = 78) 48 (61.5%) 30 (38.5%)  11 (14.1%) 18 (23.1%) 1 (1.3%)
≤ 5 cm (n = 20) 17 (85.0%) 3 (15.0%) 2 (10.0%) 1 (5.0%) 0 (0.0%)
0.200
> 10 cm (n = 49) 29 (59.2%) 20 (40.8%) 10 (20.4%) 10 (20.4%) 0 (0.0%)
≤ 10 cm (n = 49) 36 (73.5%) 13 (26.5%) 3 (6.1%) 9 (18.4%) 1 (2.0%)
0.501
> 15 cm (n = 27) 16 (59.3%) 11 (40.7%)  8 (29.6%) 3 (11.1%) 0 (0.0%)
≤ 15 cm (n = 71) 49 (69.0%) 22 (31.0%) 5 (7.1%) 16 (22.5%) 1 (1.4%)
Tumors side 0.199
unilateral (n = 74) 46 (62.2%) 28 (37.8%) 10 (13.5%) 17 (23.0%) 1 (1.4%)
bilateral (n = 24) 19 (79.2%) 5 (20.8%) 3 (12.5%) 2 (8.3%) 0 (0.0%)
Histology 0.004
serous (n = 58) 46 (79.3%) 12 (20.7%) 5 (8.6%) 7 (12.1%) 0 (0.0%)
mucinous (n = 35) 16 (45.7%) 19 (54.3%) 8 (22.9%) 10 (28.6) 1 (2.9%)
mixed (n = 5) 3 (60.0%) 2 (40.0%) 0 (0.0%) 2 (40.0%) 0 (0.0%)
 Spread outside ovary 0.901
present (n = 29) 20 (69.0%) 9 (31.0%) 5 (17.2%) 4 (13.8%) 0 (0.0%)
absent (n = 69) 45 (65.2%) 24 (34.8%) 8 (11.6%) 15 (21.7%) 1 (1.4%)
 Tumor markers 0.840 
elevation * (n = 35) 21 (60.0%) 14 (40.0%) 9 (25.7%) 5 (14.3%) 0 (0.0%)
normal (n = 27) 16 (59.3%) 11 (40.7%) 3 (11.1%) 8 (29.6%) 0 (0.0%)
Study period 0.889
2004-2009 (n = 51) 34 (66.7%) 17 (33.3%) 8 (15.7%) 9 (17.6%) 0 (0.0%)
2010-2015 (n = 47) 31 (66.0%) 16 (34.0%) 5 (10.6%) 10 (21.3%) 1 (2.1%)
Endometriosis 0.714
present (n = 8) 6 (75.0%) 2 (25.0%) 1 (12.5%) 1 (12.5%) 0 (0.0%)
absent (n = 90) 59 (65.6%) 31 (34.4%) 12 (13.3%) 18 (20.0%) 1 (1.1%)
Table 2. Tumor characteristics and accuracy of frozen section diagnosis.
* defined as CA125 > 35U/ml; CA 19.9 > 37 U/ml
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BOT 
-MALIGNANT Age
Tumor diameter 
(cm) First surgery FIGO stage Re-staging
Adjuvant 
therapy Recurrence Follow-up Notes
Serous
(n = 5)
P.C 75 5,5 Complete Ia No No No 46 months Death for other causes
U.A 31 2 Complete, LN IIIc No Yes Yes 33 months 33 months
Frozen section 
in omentum 
positive.
B.M 61 4 Complete Ia No No No 40 months
P.E 41 4 Complete Ic Yes Yes No 62 months Rising tumor markers
R.M 39 14 Complete Ic Yes Yes No 31 months
Mucinous
(n = 8)
C.L 37 21 Complete, LN Ia No No No 60 months
P.G 49 22 Complete, LN IIa Yes Yes Yes 55 months 57 months
M.M 58 36 Complete Ib No Yes No 70 months
S.A 26 18 Fertility sparing Ia No No No 84 months
P.O 67 29 Complete Ia No No No 59 months Death for other causes
C.C 33 23 Fertility sparing Ia No Yes No 42 months
D.O 46 17 Complete Ia No No No 32 months
M.F 48 28 Complete Ib Yes Yes No 6 months
Table 3. Patient’s characteristics and outcomes of Underdiagnosis.
preserving surgery. Four patients underwent a restaging procedure 
and seven patients received adjuvant chemotherapy. There were two 
relapses; in addition, one patient has rising CA 19.9 and CA125 (40 
I.U./l and 45 I.U./l respectively), but at the moment she has no clinical 
relapse. The mean follow-up is 47.8 months (31-84 months).
In the fifteen patients with BOTs underdiagnosed as benign tumors 
at frozen section that did not undergo restaging surgery, the mean 
follow-up was 60.4 months (38 - 100 months). No recurrence was 
observed.
Discussions
The appropriate surgical management of ovarian tumors requires 
accurate histological diagnosis. Benign lesions are usually managed 
conservatively, and a similar approach may be used in some patients 
with BOTs who wish to preserve fertility. Although advanced-stage 
ovarian cancer is usually evident at the time of surgery, the distinction 
of benign, borderline, and malignant tumors macroscopically confined 
to the ovaries is more difficult [11]. Frozen section diagnosis offers an 
important and helpful adjunct to the intra-operative diagnosis and has 
greatly impacted the care of gynecologic oncology patients. It also helps 
to determine the staging, as well as the appropriate surgical technique 
for each case [12]. Intra-operative diagnosis is especially important 
in women of reproductive age, in which fertility preservation is of 
paramount importance.
The accuracy of frozen section examination in diagnosing ovarian 
tumors is greater than 90% [7]. However, the accuracy of frozen section 
is lower in diagnosing BOTs [13]. In a review of the literature including 
only studies assessing the accuracy of intraoperative frozen section 
analysis in diagnosing BOTs (317 women), Tempfer et al. found that 
intraoperative frozen section has a sensitivity of 71.1% and a PPV of 
84.3% [14]. Overdiagnosis and underdiagnosis occurred in 6.6% and 
30.6% of the cases, respectively. We performed a literature research 
and identified five previous studies exclusively examining the frozen 
section diagnosis of BOTs (12-16). Data of these studies and the 
present investigation were pooled; 516 cases were identified. Table 4 
shows that agreement between frozen section diagnosis and definitive 
histology was observed in 327/516 (63.4%) patients, yielding an overall 
sensitivity of 72.2% and a PPV of 83.3% (Figure 1). Overdiagnosis 
and underdiagnosis were identified in 28/516 (5.4%) and in 161/516 
(31.2%) cases, respectively.
Permanent pathology
Frozen section Benign Borderline Malignant
Menzin et al. (1995)
Benign 0 9 0
Borderline 3 23 13
Malignant 0 0 0
Houck et al. (2000)
Benign 0 35 0
Borderline 4 84 6
Malignant 0 11 0
Kayikcioglu et al. 
(2000)
Benign 0 3 0
Borderline 3 23 4
Malignant 0 0 0
Tempfer et al. 
(2007)
Benign 0 23 0
Borderline 0 69 4
Malignant 0 0 0
Kim et al. (2009)
Benign 0 24 0
Borderline 5 63 8
Malignant 0 1 0
Current study
Benign 0 19 0
Borderline 0 65 13
Malignant 0 1 0
Pooled analysis
Benign 0 113 0
Borderline 15 327 48
Malignant 0 13 0
Table 4. Frozen section diagnosis of BOTs compared with permanent histology, individual 
data of six studies and pooled analysis.
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Figure 1. (100x) Upper Left: Frozen Section examination of a mucinous borderline tumor of intestinal type; Lower Left: Formalin Fixed - Paraffin Embedded Definitive slide of the same 
sample of a mucinous borderline tumor of intestinal type; Upper Right: Frozen Section examination of a serous borderline tumor; Lower Right:  Formalin Fixed - Paraffin Embedded 
Definitive slide of the same sample of a serous borderline tumor.
Figure 2. (200x) Upper Left: Frozen Section examination of a mucinous borderline tumor of intestinal type; Lower Left: Formalin Fixed - Paraffin Embedded Definitive slide of the 
same sample of a mucinous borderline tumor of intestinal type; Upper Right: Frozen Section examination of a serous borderline tumor. 
The results of our study demonstrate that the low sensitivity of 
frozen section examination is mainly due to the underdiagnosis of 
mucinous BOTs as benign tumors (Figures 1 and 2). The inaccuracy 
of frozen section examinations in diagnosing mucinous BOTs was 
previously reported by other authors [13-16]. The limitations of frozen 
section in diagnosing mucinous BOTs may be due to the fact that, in 
this neoplasm, invasive mucinous ovarian cancer can often be observed 
in areas adjacent to benign and borderline histology, suggesting a 
continuum to malignant progression which is not observed in the other 
epithelial ovarian lesions [17]. Adequate sampling in frozen section 
cannot sometimes be performed in mucinous tumors due to relatively 
larger size; therefore, malignant areas can be overlooked. Several 
studies showed that mucinous histology, tumor size and experience 
of the pathologist influences the accuracy of frozen section diagnosis 
[18,19]. Performing multiple sections in large tumors may increase 
the possibility to identify focal borderline changes. Tempfer et al. [14] 
observed that three out of four misread tumors have a diameter ≥ 5 cm; 
therefore, they suggested that a cut-off of 5 cm for tumor diameter is 
reasonable for recommending multiple sections. In our series, BOTs 
underdiagnosed at frozen section were significantly larger than those 
accurately diagnosed at frozen section. In addition, there was a trend 
for tumors with diameter ≤ 5 cm to be less frequently misdiagnosed 
than tumors with diameter > 5 cm, but the difference did not reach 
statistical significance (Table 2). In agreement with these observations, 
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misdiagnosis occurred in 15.0% of tumors with diameter ≤ 5 cm, in 
26.5% of tumors with diameter ≤ 10 cm and in 31.0% of tumors with 
diameter ≤ 15 cm.
In our series, the majority of the diagnostic discrepancies were 
caused by underdiagnosis and the most common single error, 
accounting for 43.8% of the cases (14/32), was the misinterpretation of 
BOTs as benign mucinous cystadenoma. Such cases present a potential 
clinical dilemma because these patients may not undergo the formal 
staging (omental biopsy or omentectomy, with or without peritoneal 
biopsy) that would normally follow a correct intraoperative diagnosis 
of BOT. In our practice, the management options (surgical restaging 
or follow-up) of these patients were determined on individual basis 
depending on the overall clinical, pathological, and operative findings.
In keeping with previous reports [8,20], we found that the 
intraoperative assessment of serous BOTs was more reliable than in 
mucinous BOTs with 86.8% of the cases accurately diagnosed.
Although patients with BOTs have an excellent prognosis, there 
is a risk of recurrence [21]. The overall false-positive rate in our 
series was 1.0% similar to the range (0.0%-2.2%) reported in previous 
studies [8,22,23]. Patients with ovarian carcinoma (but not those with 
BOTs) in our institute usually undergo unilateral retroperitoneal 
lymphadenectomy; consequently, this type of intraoperative error may 
lead to extended and unnecessary surgery. 
Therefore, the reliability of frozen-section diagnosis of BOTs 
is a critical determinant in the selection of the appropriate surgical 
procedure [24]. 
In the current study, the clinical outcome after misdiagnosis at 
frozen section was reported. No recurrence was observed in the 19 
patients with BOTs that were interpreted as benign at frozen section. 
Retrospective studies demonstrated that there is no difference in 
recurrence rates between women who undergo restaging of BOTs and 
those who do not [25-28]. Restaging procedure does not seem to have 
a significant impact on the management of patients diagnosed with 
BOTs, especially in mucinous subtype [28]. Our data are in agreement 
with those published by Kim et al. [29] and suggest that under diagnosis 
by frozen section examination does not compromise the outcome in 
patients with BOTs. In fact, although underdiagnosis was associated 
with conservative surgery, it did not cause treatment failure. These 
findings suggest that the extent of surgery is not the critical factor for 
outcome in women with BOTs.
In conclusion, the intraoperative management of BOTs needs a 
histological and surgical evaluation. An intraoperative assessment 
must be combined with a direct communication between surgeon and 
pathologist and both physicians should know the limitations of this 
examination. In particular, surgeons should be aware that frozen section 
diagnosis is based on the assessment of two to three sections from the 
most suspicious portion of the tumour, while the final diagnosis is 
made after the evaluation of an internationally agreed standard of a 
minimum of one section per cm of maximal tumour diameter [30]. 
The surgical management of BOTs based only on intraoperative frozen 
section diagnosis should be used with caution because this strategy 
may result in undertreatment of a substantial number of patients or 
overtreatment in few cases. However, when frozen section examination 
diagnose BOT in patients who do not with to preserve fertility, the 
surgeon should perform a standard staging [31]. In these cases, large 
peritoneal biopsies and deperitonealisation of all suspicious regions are 
required [32]. Obviously, a close follow-up is required in women who 
undergo a conservative treatment [33].
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